Based on the cancer response, BC can be divided into estrogen receptor (ER)-positive (response to estrogen signaling), progesterone receptor (PR)-positive (response to progesterone), ER/PR-positive, and human epidermal growth factor receptor-2 (HER2)-positive tumors [6–8]. The gene discussed is PGR; the disease is breast cancer.